Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 120

    1.

    Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.

    Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ.

    Ann Intern Med. 1992 Dec 15;117(12):997-1002.PMID: 1443986 [PubMed - indexed for MEDLINE]Related articles

    2.

    High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.

    Palosuo T, Virtamo J, Haukka J, Taylor PR, Aho K, Puurunen M, Vaarala O.

    Thromb Haemost. 1997 Oct;78(4):1178-82.PMID: 9364981 [PubMed - indexed for MEDLINE]Related articles

    3.

    A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study).

    Naess IA, Christiansen SC, Cannegieter SC, Rosendaal FR, Hammerstroem J.

    J Thromb Haemost. 2006 Jan;4(1):44-9.PMID: 16409447 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study.

    Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD.

    Br J Haematol. 2002 Dec;119(4):1005-10.PMID: 12472581 [PubMed - indexed for MEDLINE]Related articles

    5.

    High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke.

    Cojocaru IM, Cojocaru M, Iacob SA.

    Rom J Intern Med. 2005;43(1-2):89-95.PMID: 16739869 [PubMed - indexed for MEDLINE]Related articles

    6.

    Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project.

    Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK.

    Stroke. 2000 Jun;31(6):1289-93.PMID: 10835446 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.

    Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ.

    Stroke. 1994 Oct;25(10):1924-30.PMID: 8091435 [PubMed - indexed for MEDLINE]Related articles

    8.

    Value of immunologic testing in stroke patients. A prospective multicenter study.

    Montalbán J, Rio J, Khamastha M, Davalos A, Codina M, Swana GT, Calcagnotto ME, Sumalla J, Mederer S, Gil A, et al.

    Stroke. 1994 Dec;25(12):2412-5.PMID: 7974582 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

    Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators.

    JAMA. 2004 Feb 4;291(5):576-84.PMID: 14762036 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The role of persistent anticardiolipin antibody as risk factor of ischemic stroke.

    Immanuel S, Giantini A, Dharma RS, Samino.

    Acta Med Indones. 2005 Oct-Dec;37(4):205-9.PMID: 16354941 [PubMed - indexed for MEDLINE]Related articles

    11.

    Anticardiolipin antibodies are an independent risk factor for ischemic stroke.

    Zieliñska J, Ryglewicz D, Wierzchowska E, Lechowicz W, Hier DB, Czlonkowska A.

    Neurol Res. 1999 Oct;21(7):653-7.PMID: 10555186 [PubMed - indexed for MEDLINE]Related articles

    12.

    Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

    Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP.

    N Engl J Med. 1995 Apr 6;332(14):912-7.PMID: 7877648 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.

    Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME, Godbold JH.

    Stroke. 1999 Aug;30(8):1561-5.PMID: 10436101 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study.

    Tanne D, D'Olhaberriague L, Trivedi AM, Salowich-Palm L, Schultz LR, Levine SR.

    Neuroepidemiology. 2002 Mar-Apr;21(2):93-9.PMID: 11901279 [PubMed - indexed for MEDLINE]Related articles

    15.

    High titer of anticardiolipin antibody is associated with first-ever ischemic stroke in Taiwan.

    Lien LM, Chen WH, Chiu HC, Pan WH, Chen JR, Bai CH.

    Cerebrovasc Dis. 2006;22(4):225-30. Epub 2006 Jun 20.PMID: 16788294 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

    Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

    Cancer Res. 1999 Mar 15;59(6):1225-30.PMID: 10096552 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH.

    N Engl J Med. 1997 Apr 3;336(14):973-9. Erratum in: N Engl J Med 1997 Jul 31;337(5):356. PMID: 9077376 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.

    Lancet. 1997 Jan 11;349(9045):83-8.PMID: 8996419 [PubMed - indexed for MEDLINE]Related articles

    19.

    PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.

    Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K.

    Lancet. 1997 Feb 8;349(9049):385-8.PMID: 9033464 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recurrent thrombosis in patients with deep vein thrombosis and/or venous thromboembolism associated with anticardiolipin antibodies.

    de Godoy JM, de Godoy MF, Braile DM.

    Angiology. 2006 Jan-Feb;57(1):79-83.PMID: 16444460 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data